US-based CASI Pharmaceuticals has bought a portfolio of 25 US FDA-approved abbreviated new drug applications (ANDAs), one ANDA that FDA tentatively approved, an 31 January 2018
Fresenius Kabi, a company specializing in medicines and technologies for infusion, transfusion and clinical nutrition, has announced the US availability of inje 30 January 2018
Israeli drugmaker Teva has announced the launch of an authorized generic of Estrace Cream (estradiol vaginal cream, USP, 0.01%) in the USA. 3 January 2018
Israeli drugmaker Teva Pharmaceutical Industries has wasted no time in launching a generic version of a newly off-patent HIV drug with annual US sales of around 18 December 2017
A commercial stage biopharmaceutical R&D company, focused on the development of products that address the medical challenges in the therapeutic area of anti-infectives.